BioSpace News Archive

Policy

European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase III JAVELIN Bladder 100 study

January 25, 2021
·
26 min read
Policy

One-year since first Canadian COVID-19 case: the CMA calls for a clear and focused plan ahead

While these numbers are sobering, more staggering are the number of people who have died. 18,266 people in Canada have been killed by COVID-19 since the start of this pandemic.

January 25, 2021
·
2 min read
Latest findings reveal few Canadian adults have antibodies to SARS-CoV-2Highest levels recorded in Western Canada but mass national vaccination remains only route to achieving herd immunity

Canadian Blood Services and Canada’s COVID-19 Immunity Task Force are releasing new results from their collaborative nine-province SARS-CoV-2 seroprevalence study.

January 25, 2021
·
7 min read
Business

Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation

The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-generation biologic medicines

January 25, 2021
·
2 min read
Business

NEUVOGEN Appoints Dr. Christian Ottensmeier Head of Scientific Advisory Board

NEUVOGEN, an immunoncology company, is pleased to appoint Christian Ottensmeier MD, PhD, FRCP Head of our Scientific Advisory Board.

January 25, 2021
·
4 min read